For example, C1P and S1P could act as chemoattractants for tumor cells, and their increased level in several organs after radio-/chemotherapy indicates induction of an unwanted pro-metastatic environment as a side effect of oncologic treatment (45); thus, their chemotactic gradient became a legitimate target for anti-metastatic therapies (46). The gene discussed is MBTPS1; the disease is neoplasm.